Marijan Kraš

Marijan Kraš

Saved in:

Bibliographic Details
Main Authors:	Andrea Toljan, Željan Čeč
Format:	Article
Language:	English
Published:	Hrvatsko knjižničarsko društvo / Croatian Library Association 2023-11-01
Series:	Vjesnik Bibliotekara Hrvatske
Online Access:	https://izdanja.hkdrustvo.hr/casopisi/vbh/article/view/1151
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Marijan Bradanović: Branko Fučić, povjesničar umjetnosti i konzervator
by: Sunčica Mustač
Published: (2023-01-01)

Bulgaria Through the Eyes of Marijan Alkovic and Franjo Horvat Kis
by: Antoaneta Balcheva
Published: (2024-01-01)

Novak Zorica
by: Andreja Toljan
Published: (2022-05-01)

Targeting KRAS‐mutant pancreatic cancer through simultaneous inhibition of KRAS, MEK, and JAK2
by: Satoru Miyazaki, et al.
Published: (2025-02-01)

Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development
by: Han Koo, et al.
Published: (2025-01-01)

KRAS signaling in malignant pleural mesothelioma
by: Antonia Marazioti, et al.
Published: (2021-12-01)

KRAS4B is required for placental development
by: Marie-Albane Minati, et al.
Published: (2025-08-01)

Targeting KRAS in Cancer Therapy: Beyond Inhibitors
by: Chunhui Chen, et al.
Published: (2025-07-01)

Identification of cave pollution in the Kras Plateau, Slovenia
by: Jure Tičar, et al.
Published: (2018-12-01)

Motif-guided identification of KRAS-interacting proteins
by: Sanan Wu, et al.
Published: (2024-11-01)

Mutational profile of KRAS-positive colorectal cancer
by: E. N. Telysheva, et al.
Published: (2022-03-01)

Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12C
by: Masaoki Ito, et al.
Published: (2025-05-01)

Samra Azarnouche (dir.), À la recherche de la continuité iranienne. De la tradition zoroastrienne à la mystique islamique. Recueils de textes autour de l’œuvre de Marijan Molé (1924-1963)
by: Guillaume Dye
Published: (2023-07-01)

Targeting KRAS: from metabolic regulation to cancer treatment
by: Yanyan Shi, et al.
Published: (2025-01-01)

The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
by: Qinglong Ma, et al.
Published: (2025-01-01)

Computational screening of phytochemicals targeting mutant KRAS in colorectal cancer
by: Muskan Arooj, et al.
Published: (2025-08-01)

Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer
by: Nawaz Khan, et al.
Published: (2025-07-01)

KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
by: Mahmoud Yousef, et al.
Published: (2025-04-01)

DNA methylation memory of pancreatic acinar-ductal metaplasia transition state altering Kras-downstream PI3K and Rho GTPase signaling in the absence of Kras mutation
by: Emily K.W. Lo, et al.
Published: (2025-03-01)

Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration
by: Giuseppe Defazio, et al.
Published: (2025-08-01)

Analysis of the immune microenvironment in colorectal cancer with different KRAS gene subtypes
by: Jing Huang, et al.
Published: (2025-08-01)

CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
by: Sara Costa-Cabral, et al.
Published: (2016-01-01)

A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy
by: Anastasia Goloudina, et al.
Published: (2025-07-01)

Elevated KRAS protein level is associated with better survival in pancreatic cancer
by: S. M. Stålberg, et al.
Published: (2025-07-01)

Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS
by: Iwona Stelniec‐Klotz, et al.
Published: (2012-07-01)

Discovery of KRAS(G12D) selective degrader ASP3082
by: Tomohiro Yoshinari, et al.
Published: (2025-08-01)

The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer
by: M. P. Smal, et al.
Published: (2015-12-01)

Quantum biological convergence: quantum computing accelerates KRAS inhibitor design
by: Taeho Kwon, et al.
Published: (2025-05-01)

Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?
by: Shenao Fu, et al.
Published: (2025-07-01)

KRas plays a negative role in regulating IDO1 expression
by: Xiandong Peng, et al.
Published: (2025-01-01)

Cten is targeted by Kras signalling to regulate cell motility in the colon and pancreas.
by: Saleh Al-Ghamdi, et al.
Published: (2011-01-01)

Editorial: KRAS in stage IV non-small cell lung cancer
by: Anneloes L. Noordhof, et al.
Published: (2025-03-01)

Advances in Immunotherapy of KRAS-mutated Non-small Cell Lung Cancer
by: Xinyue YANG, et al.
Published: (2025-05-01)

ANALYSIS OF MUTATIONS IN KRAS AND BRAF GENES IN COLORECTAL CANCER IN RUSSIAN PATIENTS
by: E. E. Pisareva, et al.
Published: (2016-07-01)

Synergistic anticancer effects of camptothecin and sotorasib in KRAS-mutated pancreatic ductal adenocarcinoma
by: Prasanna Srinivasan Ramalingam, et al.
Published: (2025-07-01)

High-dose vitamin C as a targeted treatment for KRAS-driven cancers?
by: Elisabeth Mack, et al.
Published: (2025-09-01)

Distinct association of HRAS and KRAS with Mn2+ ion illustrated by paramagnetic NMR
by: Jia-Liang Chen, et al.
Published: (2025-02-01)

KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan.
by: Muhammad Awidi, et al.
Published: (2019-01-01)

KRAS Mutation Status in Relation to Clinicopathological Characteristics of Romanian Colorectal Cancer Patients
by: Elena-Roxana Avădănei, et al.
Published: (2025-02-01)

Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors
by: Giorgia Anastasio, et al.
Published: (2025-02-01)